• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Obstetrics

Continued versus discontinued oxytocin stimulation in the active phase of labour

byBrian DoughertyandAlex Chan
April 19, 2021
in Obstetrics
Reading Time: 2 mins read
USPSTF finds insufficient evidence for screening for iron deficiency anemia during pregnancy
Share on FacebookShare on Twitter

1. Among pregnant women, discontinuing the administration of oxytocin during the active phase of labor is associated with a small, absolute increase in the risk of cesarean delivery but significantly reduces the risk of uterine hyperstimulation and abnormal fetal heart rate.

Evidence Level Rating: 1 (Excellent)

About a quarter of all term pregnancies are induced, often with oxytocin stimulation. The use of oxytocin, however, carries with it a risk of hyperstimulation, which may lead to emergent cesarean for fetal indications secondary to uterine hyperstimulation. Recent evidence suggests that once a woman is in active labor, the labor will continue even if oxytocin is stopped; little of this evidence, though, is supported by randomized trials. As such, the aim of this double-blind, randomized controlled trial was to test whether discontinuation of oxytocin stimulation once the active phase of labor is reached reduces the overall cesarean rate. 607 women were randomized to the discontinued cohort (mean [SD] age = 31.0 [4.9] years) and 591 to the continued cohort (mean [SD] age = 31.3 [4.9] years). There was no significant difference in the rate of cesarean delivery between the discontinued (16.6%) and continued cohorts (14.2%) (RR 1.17 95% CI 0.90 to 1.53). The prespecified noninferiority testing was inconclusive (p = 0.70). Among parous women without prior cesarean, however, the risk of cesarean was substantially higher in the discontinued cohort (7.5%) compared with the continued cohort (0.6%) (RR 11.6, 95% CI 1.15 to 88.7). When reviewing secondary outcomes, it was found that the discontinuation of oxytocin was associated with a longer duration of labor, a reduced risk of uterine hyperstimulation, and a reduced risk of fetal heart rate abnormalities. There were similar rates of other adverse maternal and neonatal outcomes between the two groups. In all, this study suggests that the discontinuation of oxytocin stimulation during the active phase of labor is associated with a small, absolute increase in the risk of cesarean delivery but significantly reduces the risk of uterine hyperstimulation and abnormal fetal heart rate.

Click to read the study in BMJ

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

A health coaching intervention may improve blood pressure control in postpartum women

Medical or procedural abortion may not increase risk of psychotropic medication use after five years

Epidural analgesia in labour is not associated with adverse neonatal health outcomes

Tags: labourobstetrics
Previous Post

2 Minute Medicine Rewind April 19, 2021

Next Post

Tdap vaccine during pregnancy not linked to adverse childhood health outcomes

RelatedReports

Prevalence of hypertension among adolescents varies by race and BMI
Cardiology

A health coaching intervention may improve blood pressure control in postpartum women

August 12, 2026
Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial
Chronic Disease

Medical or procedural abortion may not increase risk of psychotropic medication use after five years

July 27, 2026
Behavioral dysregulation in infancy predicts later child mental health
Imaging and Intervention

Epidural analgesia in labour is not associated with adverse neonatal health outcomes

July 23, 2026
Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial
Weekly Rewinds

2 Minute Medicine Rewind July 20, 2026

July 20, 2026
Next Post
Compliance-linked incentives increase infant immunizations rates in rural India

Tdap vaccine during pregnancy not linked to adverse childhood health outcomes

Patients with low back pain or pain at multiple sites at highest risk for chronic opioid use

Hospitalized patients with substance use disorder benefit from navigation services

Reducing primary care physician shortage in low-density areas increases life expectancy

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Daraxonrasib extends survival in metastatic pancreatic cancer
  • Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being
  • A lower threshold for referral to the emergency department for outpatient hyperkalemia may reduce mortality
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.